Carapinha & Company

@Carapinha_Co

Improving market access through stronger pharmaceutical markets. RT ≠ endorsement. Founder

Vrijeme pridruživanja: svibanj 2016.

Tweetovi

Blokirali ste korisnika/cu @Carapinha_Co

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Carapinha_Co

  1. proslijedio/la je Tweet
    Poništi
  2. proslijedio/la je Tweet
    4. velj

    📣 New job opportunities at the Alliance 📢 We're looking for a new Technical Officer who will work on teaching, learning and capacity strengthening in and a Scientist to lead several techincal portfolios. Apply through Careers:

    Vacancy notice

Technical Officer, Alliance for HPSR
WHO HQ in Geneva, Switzerland

Focus on teaching, learning and capacity strengthening on HPSR

Deadline for applications: 24 February 2020, 23:59 CET
    Vacancy notice

Scientist, 
Alliance for HPSR
WHO HQ in Geneva, Switzerland

Managing portfolios on HPSR synthesis, embedded research and primary health care

Deadline for applications: 24 February 2020, 23:59 CET
    Poništi
  3. proslijedio/la je Tweet
    4. velj
    Poništi
  4. proslijedio/la je Tweet
    31. sij

    ¿Te interesa la ? Si eres te invitamos a realizar este Test de Competencias Digitales para que puedas medir tus conocimientos de cinco áreas de competencia digtal

    Poništi
  5. proslijedio/la je Tweet
    31. sij

    La afinidad entre emprendedor y mentor es clave en un programa de apoyo a startups. Por eso, desde hemos conectado a de , aficionada a la gamificación y a la tecnología, con Daniel González, IT Manager de

    Poništi
  6. proslijedio/la je Tweet

    One of the most critical problems facing our world today is the number of children living in extreme poverty who cannot access routine immunizations. Tell world leaders to invest in life-saving vaccines by supporting .

    Poništi
  7. proslijedio/la je Tweet
    29. sij

    In this open access 🔓 article, the authors discuss how extrapolation of clinical trial data is improved by using historical trial data-based a priori distributions.

    Poništi
  8. proslijedio/la je Tweet
    29. sij

    Looking at the past, mirroring the future of HTA in Latin America

    Poništi
  9. proslijedio/la je Tweet

    "J'ai hâte de suivre cette importante Formation des Médias sur la Santé Merck le 30 janvier 2020 au Radisson Blu Hotel, N'Djamena Tchad."~ Dr. Rasha Kelej, CEO Merck Foundation & President of Merck More than a Mother.

    Poništi
  10. proslijedio/la je Tweet
    28. sij

    New patent expiration for Leo Pharma drug TACLONEX (via DrugPatentWatch)

    Poništi
  11. proslijedio/la je Tweet
    27. sij

    Martin Shkreli is sued by the FTC and NY attorney general for cornering the market on a drug.. read the lawsuit here..

    Poništi
  12. proslijedio/la je Tweet
    27. sij

    Our library of publications on health & disease collects 12 years' worth of work on the social science and politics of One Health, zoonotic diseases, outbreaks, environmental health and more

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    24. sij

    Wow! This blog by R4Der includes a fascinating list of global initiatives. We are very excited to work with our partners to learn more about which of these can achieve impact and scale

    Poništi
  14. proslijedio/la je Tweet
    23. sij

    Two weeks ahead of schedule, notices of decisions have been emailed to all those who submitted an organized session abstract for the Sixth Global Symposium on Health Systems Research . Please check your inboxes! Read more via

    Poništi
  15. proslijedio/la je Tweet

    Today, we're celebrating by continuing to share with educators and students all around the globe. Equal access to science learning resources is critical to ensuring science literacy for all.

    Poništi
  16. proslijedio/la je Tweet
    24. sij

    Our Model School Development Program contributed to improvement of the quality of learning environment in government schools by upgrading infrastructure & introducing better learning tools.

    Poništi
  17. proslijedio/la je Tweet
    23. sij

    Register for ISPOR 2020 to learn how HEOR advances evidence into action along the decision-making continuum spanning research and development, innovation, health policy, clinical practice, & patient perspectives around the globe.

    Poništi
  18. proslijedio/la je Tweet
    23. sij

    ISPOR 2020 Top 10 HEOR Trends—#9 Aging Population This global demographic trend will have a long-term impact on healthcare delivery & costs for some time to come. More on the Top 10 HEOR Trends at .

    Poništi
  19. proslijedio/la je Tweet
    21. sij

    As one of the few major companies continuing to invest in AMR research, we welcome the AMR Benchmark Report and its findings. Phil Thomson, President, Global Affairs at GSK, shares his view on the need for action to ensure continued progress:

    ATMI - AMR
    Poništi
  20. proslijedio/la je Tweet
    21. sij

    This article provides an overview of Japan's new HTA policy, launched in April of 2019 formally after a pilot program.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·